Startups are betting on a legalized peptide market
Summary
Marketplace Tech explores the booming peptide market, where startups are racing to capitalize on potential FDA regulatory changes in July. Host Stephanie Hughes speaks with Zara Stone about how companies are navigating legal gray areas by selling "research-only" peptides despite significant health risks like cancer and infection. The episode highlights the surge in venture capital funding and celebrity endorsements driving this trend, even as enforcement remains lax.
Topics discussed
Ad: Odoo all-in-one business software
Ad: Optum connecting patient care and pharmacy
Intro: The rising popularity of peptides
FDA hearing and startup strategies for peptides
How startups navigate legal gray areas and funding
Ad: Dell Pro laptop for focus and productivity
Ad: QuickBooks Workforce and conservation impact
Health risks: Cancer, infections, and lack of data
Why peptides are trending: Celebrities and FOMO
FDA enforcement challenges and future outlook
Outro and NYC Now podcast promotion
Listen ad-free on Castria